Implantable cardioverter-defibrillators in patients with Chagas heart disease: Misperceptions, many questions and the urgent need for a randomized clinical trial

Journal of Cardiovascular Electrophysiology

Volumn 18, Issue 12, 2007, Pages 1241-1243

  Rassi Jr , Anis ^a  

^a Anis Rassi Hospital   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

CARDIAC PATIENT; CHAGAS DISEASE; DEFIBRILLATOR; DRUG MEGADOSE; HEART ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANT; NOTE; PERCEPTION; PRIORITY JOURNAL;

BRAZIL; CHAGAS CARDIOMYOPATHY; CHRONIC DISEASE; COMORBIDITY; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TACHYCARDIA, VENTRICULAR;

EID: 36148951801     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2007.01011.x     Document Type: Note

References (22)

1. Rassi A Jr., Rassi A, Little WC : Chagas' heart disease. Clin Cardiol 2000 23 : 883 889.
2. Chagas C : O Mal de Chagas. Archivos da Sociedade de Medicina e Cirurgia de São Paulo 1912 3 : 34 66.
3. Rassi A Jr., Rassi SG, Rassi A : Sudden death in Chagas' disease. Arq Bras Cardiol 2001 76 : 75 96.
4. Rassi A, Rassi A, Little WC, Xavier SS, Rassi SG, Rassi AG, Rassi GG, Hasslocher Moreno A, Sousa AS : Scanavacca MI: Development and validation of a risk score for predicting death in Chagas' heart disease. N Engl J Med 2006 355 : 799 808.
5. Ezekowitz JA, Armstrong PW, McAlister FA : Implantable cardioverter defibrillators in primary and secondary prevention: A systematic review of randomized, controlled trials. Ann Intern Med 2003 138 : 445 452.
6. Muratore C, Rabinovich R, Iglesias R, González M, Darú V, Liprandi AS : Implantable cardioverter defibrillators in patients with Chagas' disease: Are they different from patients with coronary disease? Pacing Clin Electrophysiol 1997 20 : 194 197.
7. Rabinovich R, Muratore C, Iglesias R, Gonzalez M, Darú V, Valentino M, Liprandi AS, Luceri R : Time to first shock in implantable cardioverter defibrillator (ICD) patients with Chagas cardiomyopathy. Pacing Clin Electrophysiol 1999 22 : 202 205.
8. Martinelli Filho M, De Siqueira SF, Moreira H, Fagundes A, Pedrosa A, Nishioka SD, Costa R, Scanavacca M, D'Avila A, Sosa E : Probability of occurrence of life-threatening ventricular arrhythmias in Chagas' disease versus non-Chagas' disease. Pacing Clin Electrophysiol 2000 23 : 1944 1946.
9. Cardinalli-Neto A, Greco OT, Bestetti RB : Automatic implantable cardioverter-defibrillators in Chagas' heart disease patients with malignant ventricular arrhythmias. Pacing Clin Electrophysiol 2006 29 : 467 470.
10. da Fonseca SM, Belo LG, Carvalho H, Araújo N, Munhoz C, Siqueira L, Maciel W, Andréa E, Atié J : Clinical follow-up of patients with implantable cardioverter-defibrillator. Arq Bras Cardiol 2007 88 : 8 16.
11. Dubner S, Valero E, Pesce R, Zuelgaray JG, Mateos JC, Filho SG, Reyes W, Garillo R: A Latin American registry of implantable cardioverter defibrillators: The ICD-LABOR study. Ann Noninvasive Electrocardiol 2005 10 : 420 428.
12. Cardinalli-Neto A, Bestetti RB, Cordeiro JA, Rodrigues VC : Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy. J Cardiovasc Electrophysiol 2007 18 : 1236 1240.
13. Ezekowitz JA, Rowe BH, Dryden DM, Hooton N, Vandermeer B, Spooner C, McAlister FA : Systematic review: Implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction. Ann Intern Med 2007 147 : 251 262.
14. Scanavacca MI, Sosa EA, Lee JH, Bellotti G, Pileggi F : Empiric therapy with amiodarone in patients with chronic Chagas cardiomyopathy and sustained ventricular tachycardia [article in Portuguese]. Arq Bras Cardiol 1990 54 : 367 371.
15. Leite LR, Fenelon G, Paes AT, de Paola AA : The impact of syncope during clinical presentation of sustained ventricular tachycardia on total and cardiac mortality in patients with chronic Chagasic heart disease. Arq Bras Cardiol 2001 77 : 439 452.
16. Lorga Filho AM : The influence of sustained ventricular tachycardia on the long term survival of clinically treated chagasic patients: A case-control study - São Paulo [in Portuguese], 2002, 98, Thesis, University of São Paulo.
17. Leite LR, Fenelon G, Simoes A Jr., Silva GG, Friedman PA, de Paola AA : Clinical usefulness of electrophysiologic testing in patients with ventricular tachycardia and chronic chagasic cardiomyopathy treated with amiodarone or sotalol. J Cardiovasc Electrophysiol 2003 14 : 574 577.
18. Sarabanda AVL, Marin-Neto JA : Long-term outcomes and predictors of total mortality and sudden cardiac death in patients with Chagas heart disease and ventricular tachycardia. In press.
19. Runsio M, Bergfeldt L, Brodin LA, Ribeiro A, Samuelsson S, Resenqvist M : Left ventricular function after repeated episodes of ventricular fibrillation and defibrillation assessed by transesophageal echocardiography. Eur Heart J 1997 18 : 124 131.
20. Hurst TM, Hinrichs M, Breidenbach C, Katz N, Waldecker B : Detection of myocardial injury during transvenous implantation of automatic cardioverter-defibrillators. J Am Coll Cardiol 1999 34 : 402 408.
21. Lobo TJ, Mateos EIP, Mateos JCP, Albornoz RN : Chagas disease treatment with automatic implantable cardioverter-defibrillator [article in Portuguese]. Rev Soc Cardiol Estado São Paulo 2004 2 : 380 389.
22. Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, Greene HL, Boczor S, Domanski M, Follmann D, Gent M, Roberts RS : Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Eur Heart J 2000 21 : 2071 2078.